At a clinic in Kolkata, 62-year-old Anjali Mukherjee began taking a small probiotic capsule each morning alongside her antidepressant medication—and within weeks, the weight on her chest began to lift. She wasn’t alone. In a pilot clinical trial led by Indian researchers, older adults with moderate depression who added a daily probiotic to their treatment saw greater relief from symptoms than those who took a placebo. The study, published in the Journal of the American Geriatrics Society, adds compelling evidence to the growing understanding of the gut-brain connection—a biological dialogue where the trillions of microbes in our digestive tract may influence not just digestion, but mood and mental resilience.
All 58 participants in the trial were aged 60 or older and receiving standard antidepressant therapy. Half were randomly assigned to take a daily probiotic supplement, while the other half received a placebo, with neither the patients nor the researchers knowing who received which until the trial ended. Over 12 weeks, both groups improved—reflecting the effectiveness of existing treatments—but those on probiotics reported significantly greater reductions in both depression and anxiety symptoms. Even more telling, blood tests revealed increased levels of brain-derived neurotrophic factor (BDNF), a protein linked to neuron health and often found at lower levels in people with depression. Fecal microbiota profiling further showed measurable shifts in gut bacteria composition, reinforcing the biological plausibility of the effect.
While the study found no significant difference in overall quality of life between the groups—a reminder that symptom relief doesn’t always translate to broader well-being—the safety and simplicity of probiotics make them a promising adjunct therapy. “The results of our study are novel, and we are now planning a follow-up, larger-scale clinical trial due to the encouraging findings,” said Dr. Saibal Das of the Indian Council of Medical Research – National Institute for Research in Bacterial Infections in Kolkata. His colleague, Dr. Abhinaba Ghosh, a physician-neuroscientist at Tata Medical Center, envisions a future where low-cost, accessible interventions like probiotics could expand mental health care across India and beyond.
Though larger, more diverse trials are needed to confirm these findings, this small study offers a hopeful signal: that healing the gut might, in some cases, help heal the mind. For millions living with depression—especially in regions where mental health resources are scarce—this could be the beginning of a gentler, more holistic path to recovery.